The updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.

Updated AUA guidelines on BPH: What urologists need to know

"My conclusion is to do what you know best, learn a new technology from an expert, and consider participating in a clinical trial,” writes Gopal H. Badlani, MD.

Alternatives to TURP: Consider these variables

Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.

Bicycle riding: Good or bad for men’s health?

Findings from a longitudinal cohort study provide an evidence base for counseling patients about pain and recovery following ureteroscopy for nephrolithiasis.

Pain interference more pronounced following URS

A significant trend is occurring in the management of urethral stricture, with increased utilization of urethroplasty and decreased utilization of repeat endoscopic procedures, researchers at the University of Washington in Seattle report.

Study: Urethroplasty use on the rise

Providers should incorporate discussion of dietary supplements into patient counseling, Kevin Koo, MD, MPH, MPhil, advises.

Most supplements for stones not backed by science

A course of treatment with prednisone may offer improvement in mean total motile count for men who undergo vasectomy reversal and subsequently have partial or complete anastomotic obstruction, according to a recent study.

Prednisone may improve total motile count post vasectomy reversal

A study of kidney stone patients who were treated using ureteral access sheaths found no evidence of ureteral strictures an average of 4 years following ureteroscopy.

Sheath use not linked with strictures

Single-access percutaneous nephrolithotomy can clear the vast majority of staghorn stones with minimal morbidity, said Tim Large, MD, at the 2019 World Congress of Endourology and SWL in Abu Dhabi.

Single-access PCNL feasible for first-line treatment of staghorn calculi

Pharmacotherapy for reducing risk of stone recurrence is best reserved for patients with more aggressive disease who are at higher risk for another stone-related event, said Brett A. Johnson, MD, at the 2019 World Congress of Endourology and SWL in Abu Dhabi.

Pharmacotherapy reduces recurrence risk for aggressive stone disease

"In this era of BCG shortage, we may be forced to develop new standards and alternative strategies for bladder preservation," writes Badar M. Mian, MD.

Vol 48 No 3